Narrative Update • May 12
Have your own idea? Try our Stock Screener
French (CAC) Healthcare Sector Analysis
UpdatedMay 29, 2026
DataAggregated Company Financials
Companies55
- 7D-0.4%
- 3M-12.8%
- 1Y-15.1%
- YTD-17.9%
The Healthcare is pretty flat in the last 7 days, but ABIVAX Société Anonyme has stood out, gaining 8.0%. Unfortunately though, the industry is down 15% over the past 12 months. Looking forward, earnings are forecast to grow by 18% annually.
Sector Valuation and Performance
Has the French Healthcare Sector valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Fri, 29 May 2026 | €244.8b | €117.9b | €7.4b | 19x | 33.1x | 2.1x |
| Sun, 26 Apr 2026 | €252.6b | €117.2b | €7.5b | 19.3x | 33.6x | 2.2x |
| Tue, 24 Mar 2026 | €252.8b | €117.1b | €7.5b | 19.5x | 33.8x | 2.2x |
| Thu, 19 Feb 2026 | €280.0b | €117.1b | €7.6b | 22.3x | 36.7x | 2.4x |
| Sat, 17 Jan 2026 | €301.6b | €114.8b | €9.2b | 21.2x | 32.7x | 2.6x |
| Mon, 15 Dec 2025 | €297.7b | €114.8b | €9.5b | 19.7x | 31.4x | 2.6x |
| Wed, 12 Nov 2025 | €319.8b | €114.8b | €9.5b | 21.8x | 33.6x | 2.8x |
| Fri, 10 Oct 2025 | €298.8b | €114.7b | €9.4b | 21.3x | 31.7x | 2.6x |
| Sun, 07 Sep 2025 | €281.9b | €114.6b | €9.3b | 18.9x | 30.4x | 2.5x |
| Tue, 05 Aug 2025 | €283.8b | €114.3b | €9.3b | 20x | 30.5x | 2.5x |
| Thu, 03 Jul 2025 | €277.8b | €112.6b | €9.0b | 21.9x | 30.9x | 2.5x |
| Sat, 31 May 2025 | €283.6b | €112.6b | €8.8b | 22.9x | 32.2x | 2.5x |
| Mon, 28 Apr 2025 | €292.2b | €112.5b | €8.9b | 22.1x | 32.7x | 2.6x |
| Wed, 26 Mar 2025 | €317.7b | €111.3b | €10.2b | 23.5x | 31.2x | 2.9x |
| Fri, 21 Feb 2025 | €328.0b | €110.9b | €9.9b | 24.4x | 33.2x | 3x |
| Sun, 19 Jan 2025 | €296.5b | €113.9b | €9.1b | 20.3x | 32.7x | 2.6x |
| Tue, 17 Dec 2024 | €278.4b | €113.9b | €9.1b | 21.8x | 30.7x | 2.4x |
| Thu, 14 Nov 2024 | €280.5b | €114.0b | €9.1b | 22.2x | 31x | 2.5x |
| Sat, 12 Oct 2024 | €287.2b | €112.6b | €8.8b | 22.7x | 32.6x | 2.6x |
| Mon, 09 Sep 2024 | €288.7b | €112.0b | €8.6b | 22.2x | 33.5x | 2.6x |
| Wed, 07 Aug 2024 | €271.8b | €111.6b | €8.7b | 22.2x | 31.4x | 2.4x |
| Fri, 05 Jul 2024 | €264.9b | €110.0b | €9.0b | 23.6x | 29.3x | 2.4x |
| Sun, 02 Jun 2024 | €270.2b | €110.0b | €9.0b | 24.1x | 29.9x | 2.5x |
| Tue, 30 Apr 2024 | €271.4b | €104.9b | €7.6b | 23.8x | 35.8x | 2.6x |
| Thu, 28 Mar 2024 | €279.5b | €104.7b | €8.6b | 21.2x | 32.5x | 2.7x |
| Sat, 24 Feb 2024 | €269.9b | €104.6b | €9.0b | 20.8x | 29.8x | 2.6x |
| Mon, 22 Jan 2024 | €263.1b | €104.0b | €12.7b | 21.4x | 20.7x | 2.5x |
| Wed, 20 Dec 2023 | €261.3b | €104.0b | €12.7b | 20.9x | 20.6x | 2.5x |
| Fri, 17 Nov 2023 | €246.8b | €104.0b | €12.7b | 20.4x | 19.4x | 2.4x |
| Sun, 15 Oct 2023 | €264.3b | €104.8b | €12.5b | 19.6x | 21.2x | 2.5x |
| Tue, 12 Sep 2023 | €277.5b | €104.9b | €12.4b | 22x | 22.5x | 2.6x |
| Thu, 10 Aug 2023 | €272.9b | €104.5b | €12.5b | 21x | 21.8x | 2.6x |
| Sat, 08 Jul 2023 | €259.8b | €103.8b | €12.4b | 18.8x | 20.9x | 2.5x |
| Mon, 05 Jun 2023 | €267.0b | €108.3b | €12.1b | 21.1x | 22.1x | 2.5x |
Price to Earnings Ratio
22.1x
Current Industry PE
- Investors are optimistic on the French Healthcare industry, and appear confident in long term growth rates.
- The industry is trading at a PE ratio of 33.1x which is higher than its 3-year average PE of 29.6x.
- The 3-year average PS ratio of 2.5x is higher than the industry's current PS ratio of 2.1x.
Past Earnings Growth
- The earnings for companies in the Healthcare industry have declined 15% per year over the last three years.
- Meanwhile revenues for these companies have grown 2.9% per year.
- This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.
Industry Trends
Which industries have driven the changes within the French Healthcare sector?
| FR Market | 1.56% | |
| Healthcare | -0.39% | |
| Biotech | 6.27% | |
| Healthtech | 3.40% | |
| Healthcare Services | 2.79% | |
| Life Sciences | 1.05% | |
| Medical Equipment | -0.35% | |
| Pharma | -1.64% | |
Industry PE
- Investors are most optimistic about the Life Sciences industry even though it's trading below its 3-year average PE ratio of 46.5x.
- Analysts are expecting annual earnings growth of 19.6%, which is higher than its past year's earnings growth of 16.8% per year.
Forecasted Growth
- Analysts are most optimistic on the Biotech industry, expecting annual earnings growth of 61% over the next 5 years.
- This is better than its past earnings growth rate of 22% per year.
- In contrast, the Medical Equipment industry is expected to see its earnings grow by 13% per year over the next few years.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| EL EssilorLuxottica Société anonyme | €175.15 | 1.1% +€873.5m | -28.4% | PE34.8x | |
| DIM Sartorius Stedim Biotech | €178.10 | 4.3% +€720.0m | -8.2% | PE64.6x | |
| ABVX ABIVAX Société Anonyme | €113.40 | 7.1% +€597.7m | 2,047.7% | PS1836.9x | |
| BIM bioMérieux | €74.35 | 1.4% +€123.9m | -37.0% | PE22.1x | |
| GDS Ramsay Générale de Santé | €11.50 | 8.0% +€93.8m | 6.5% | PS0.2x |
